Elisabet Manasanch, MD,
MD Anderson Cancer Center
Interview Date: October 27, 2021
Thanks to our episode sponsor
Smoldering myeloma is evolving in thought and in treatment. In this comprehensive program, Elisabet Manasanch, MD of MD Anderson Cancer Center shares an update on the the treatment of smoldering myeloma in today's clinic. She shares treatment approaches to smoldering myeloma and shares her suggestions about protecting smoldering myeloma patients long-term with various treatment strategies. Dr. Manasanch shares two interesting clinical trials now open for smoldering myeloma patients - a customized vaccine to help prevent progression in smoldering myeloma and the use of BLENREP to prevent progression. Dr. Manasanch reviews the current thinking behind the precursor conditions and how they apply both in research and in practice.
Dr. Manasanch specializes in the treatment of patients with multiple myeloma. Furthermore, she focuses on translational research of the precursor stages of myeloma and early disease management through groundbreaking immunotherapy-focused clinical trials.
Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.
Thank you for your interest in the event. If you have any questions, we would love to help!
Feel free to give us a call or send us a message below.
+1 800 709 1113
Support@healthtree.org
Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.